Societal and policy aspects of the introduction of nanotechnology in healthcare Online publication date: Thu, 20-Jul-2006
by D.G. Rickerby
International Journal of Healthcare Technology and Management (IJHTM), Vol. 7, No. 6, 2006
Abstract: It is anticipated that the application of biomedical nanotechnology will lead to progress in medical science in the areas of disease diagnosis, bio-compatible materials and drug delivery systems. In vitro diagnostic techniques employing biosensors and biochips are already available, while advances in bioengineering include biomimetic nanostructures for surgical implants and tissue engineering. Therapeutic systems using nanopowders and nanotubes for drug delivery and anticancer drugs targeted directly at tumour cells are also being developed. Public acceptance of nanotechnology is likely to be strongly influenced by the perception of the associated risks. It is therefore essential to establish an appropriate legal and ethical framework for the implementation of nanotechnology in healthcare applications. The adoption of a precautionary approach, based on the use of reliable scientific data, is advisable in order to reduce the level of risk.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Healthcare Technology and Management (IJHTM):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook